Reaction

Haemangioma reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 2,289 reports · 49 co-occurring drugs

As of the last recalculation, Haemangioma appears in 2,289 FAERS reports alongside 49 co-occurring drug terms. The strongest observed disproportionality signal is PROPRANOLOL HYDROCHLORIDE (PRR 51.6).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Propranolol Hydrochloride	348	51.6	51.8
Zidovudine	29	20.0	20.0
Ado-Trastuzumab Emtansine	13	14.1	14.1
Progesterone	34	13.7	13.7
Vigabatrin	21	13.2	13.2
Valproate Sodium	28	12.5	12.5
Chlorhexidine Gluconate	10	10.0	10.0
Torsemide	33	9.2	9.2
Valproic Acid	31	9.1	9.1
Mometasone	17	8.5	8.5
Lamivudine	28	8.3	8.3
Terbinafine Hydrochloride	8	8.2	8.2
Blinatumomab	9	7.9	7.9
Diclofenac Potassium, Film Coated	7	7.6	7.6
Diclofenac Potassium Tablets	7	7.6	7.6
Valsartan Oral	44	7.5	7.5
Carbamazepine	54	7.5	7.5
Clobazam	19	7.1	7.1
Dolutegravir Sodium	7	7.1	7.1
Phenytoin	16	7.0	7.0
Fulvestrant	25	6.9	7.0
Timolol	9	6.8	6.8
Diclofenac Potassium	8	6.8	6.8
Clarithromycin	25	6.7	6.7
Isosorbide Dinitrate	14	6.6	6.6
Misoprostol	7	6.6	6.6
Fingolimod Hcl	58	6.2	6.2
Testosterone Cypionate	6	6.1	6.1
Norepinephrine	7	6.0	6.0
Palivizumab	10	5.9	5.9
Iron Sucrose	6	5.7	5.7
Phenobarbital	9	5.7	5.7
Sevoflurane	5	5.5	5.5
Lamivudine Oral	15	5.4	5.4
Imatinib	10	5.2	5.2
Norepinephrine Bitartrate	8	5.1	5.1
Dronedarone	5	4.5	4.5
Desoximetasone	9	4.3	4.3
Crizotinib	6	4.3	4.3
Ifosfamide	9	3.8	3.8
Interferon Beta-1B	8	3.8	3.8
Pertuzumab	11	3.7	3.7
Asfotase Alfa	4	3.6	3.6
Lapatinib	6	3.5	3.5
Docetaxel Anhydrous	24	3.3	3.3
Docetaxel	24	3.3	3.3
Alpelisib	3	3.1	3.1
Bictegravir Sodium, Emtricitabine, And Tenofovir Alafenamide Fumarate	5	2.5	2.5
Rimegepant Sulfate	3	2.2	2.2

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.